Sensei Biotherapeutics, Inc. (SNSE) Misses Q1 EPS by 4c

Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) reported Q1 EPS of ($0.27), $0.04 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Sensei Biotherapeutics, Inc. (SNSE) click here.

You May Also Be Interested In

• Intel (INTC) PT Lowered to $92 at Mizuho
• After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
• UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance